CRSRAugust 7, 2026 at 5:24 PM UTCTechnology Hardware & Equipment

WAIT Maintained: Mixed Q2 Keeps CRSR in the Penalty Box

Read source article

What happened

Corsair's Q2 2026 earnings call confirmed revenue of $307M and adjusted EBITDA of $14M, landing within management's guided range but failing to ignite any upgrade catalysts. Gamer & Creator Peripherals grew 11% YoY, though segment gross margin slipped 80bps to 40.0% as elevated promotions and the residual 10% import tariff more than offset product mix gains. Gaming Components & Systems revenue fell 13% YoY, as management reiterated that ongoing semiconductor supply constraints and elevated memory pricing continue to suppress DIY build volumes, with no near-term relief in sight. The company repurchased only $2.5M in shares during the quarter, leaving $42.5M remaining under its authorization, which does little to alter the capital-return narrative while the $300M shelf registration remains entirely unsold. Overall, the call reinforced a two-speed reality: peripherals growth is being consumed by margin compression, and the larger components segment remains hostage to a prolonged memory crisis, making the current $7.10 share price and 12.5x EV/EBITDA look fairly valued given the lack of near-term catalysts.

Implication

The Q2 print keeps CRSR in a value trap zone: revenue and profitability metrics landed within guidance, but the underlying dynamics—peripherals margin erosion from tariffs/promotions, components decline tied to semiconductor shortages—remain unchanged and align with our base-case scenario. With no near-term resolution in sight for memory constraints (IDC expects tightness through 2027) and tariff impacts unlikely to be fully offset, the stock's 12.5x EV/EBITDA multiple does not offer compensation for the risk that gross margin could slip below 31% or components decline accelerates. Until management demonstrates consecutive quarters of peripherals gross margin expansion (≥100bps YoY) and components revenue stabilization or growth, the $5.50 attractive entry price remains the more prudent target, and we advise against deploying new capital at current levels.

Thesis delta

The thesis remains unchanged: CRSR is a WAIT. Q2 results confirmed continued top-line divergence with no proof of peripherals profit-engine repair or components recovery. The margin-of-safety at $7.10 is insufficient to warrant adding exposure ahead of Q3 data that must show genuine inflection in both segments.

Confidence

high